Brief SEE FAR CBT Intervention Compared With Treatment as Usual for Adults With PTSD (NCT07710573) | Clinical Trial Compass
RecruitingNot Applicable
Brief SEE FAR CBT Intervention Compared With Treatment as Usual for Adults With PTSD
Israel60 participantsStarted 2026-07
Plain-language summary
This clinical intervention study evaluates a newly developed Brief SEE FAR CBT protocol for adults aged 18 years and older with posttraumatic stress disorder (PTSD), compared with dynamic psychotherapy treatment as usual. Participants in the Brief SEE FAR CBT group will receive 6 focused sessions emphasizing intrusive PTSD symptoms and will then continue to complete the full 12-session SEE FAR CBT protocol. Participants in the control group will receive dynamic psychotherapy as treatment as usual. Psychological outcomes will be assessed using self-report questionnaires at four time points: baseline, after 6 sessions, after 12 sessions, and at a 3-month follow-up. The study aims to examine changes in PTSD symptoms, anxiety, depression, perceived stress, resilience, somatic symptoms, sleep quality, and related psychological outcomes over the course of treatment and follow-up.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria
Participants must meet all of the following criteria:
* Age 18 years or older
* PTSD symptoms, defined as a PCL-5 score of 30-60
* Hebrew-speaking
* Able to provide informed consent
* Willing and able to participate in the assigned psychological intervention and complete study questionnaires at baseline, after 6 sessions, after 12 sessions, and at 3-month follow-up Exclusion Criteria
Participants will be excluded if they meet any of the following criteria:
* Pregnancy at the time of enrollment, due to the potential influence of pregnancy and childbirth during the treatment or follow-up period on psychological outcomes
* Currently receiving psychotherapy of any type that began less than 3 months prior to enrollment
* Initiation of psychiatric medication less than 3 months prior to enrollment
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is testing a 'Brief SEE FAR CBT' intervention against treatment as usual for PTSD — can you explain what SEE FAR CBT actually involves day-to-day, and how it differs from standard PTSD treatments I might already be a candidate for?
2Since this study has no assigned phase and is comparing a brief psychological intervention to usual care, what does that tell us about how much is already known about its safety and effectiveness for people in my specific situation?
3The trial measures changes in both PTSD and anxiety symptoms — given my current symptom profile, do you think those are the right outcomes to be tracking for me, or are there other aspects of my wellbeing that matter more right now?
4If I enroll and happen to be assigned to 'treatment as usual,' what would that actually look like for me — would it be equivalent to what you'd recommend outside of the trial, or could I be getting less intensive support?
5Are there established first-line PTSD treatments, like prolonged exposure or EMDR, that I should consider trying before exploring whether this trial might be worth discussing further with you?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in PTSD symptoms
Timeframe: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention
2
Change in anxiety symptoms
Timeframe: Baseline, 6 weeks after baseline, 12 weeks after baseline, and 3 months after completion of the intervention